Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer

Ros, J; Saoudi, N; Baraibar, I; Salva, F; Tabernero, J; Elez, E

Elez, E (通讯作者)，Vall Dhebron Inst Oncol, Dept Med Oncol, Ctr Cellex, Carrer de Natzaret 115 117, Barcelona 08035, Spain.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022; 15 ():

Abstract

B-type RAF (BRAF)-V600E mutations in metastatic colorectal cancer (mCRC) have been described in up to 12% of the patients. This mutation confers a bad......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索